CEimpact Podcast
Remdesivir for COVID-19: The NIAID Study Behind its Approval | GameChangers
June 12, 2020
Pharmacy Podcast Network
Season 11
Episode 1028
Remdesivir for COVID-19: The NIAID Study Behind its Approval | GameChangers
CEimpact Podcast
More Info
Share
CEimpact Podcast
Remdesivir for COVID-19: The NIAID Study Behind its Approval | GameChangers
Jun 12, 2020
Season 11
Episode 1028
Pharmacy Podcast Network
Recently, Remdesivir was given Emergency Use Authorization (EUA) status by the U.S. Food and Drug Administration (FDA) for use in COVID based on a heretofore unpublished study. The study, conducted by NIAID, is the subject of this episode.This episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/3hn191p See omnystudio.com/listener for privacy information.
Recently, Remdesivir was given Emergency Use Authorization (EUA) status by the U.S. Food and Drug Administration (FDA) for use in COVID based on a heretofore unpublished study. The study, conducted by NIAID, is the subject of this episode.This episode is accredited for CPE. For CE details and to claim credit click here: https://bit.ly/3hn191p See omnystudio.com/listener for privacy information.